Callan JMB Signs Manufacturing Oversight, Federal Deployment, And Commercialization Agreement Of Multi-Asset Therapeutic Pipeline With Attune For Approximately $50 To $75 Million In Total Revenue
CALLAN JMB SIGNS MANUFACTURING OVERSIGHT, FEDERAL DEPLOYMENT, AND COMMERCIALIZATION AGREEMENT OF MULTI-ASSET THERAPEUTIC PIPELINE WITH ATTUNE FOR APPROXIMATELY $50 TO $75 MILLION IN TOTAL REVENUE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.